Status of Bone Mineral Density in Patients with Hyperthyroidism

Dr. Dinesh K Dhanwal, Vivek Dixit, R K Marwah

Abstract


Vitamin D deficiency is widely prevalent in patients with hyperthyroidism along with lower bone mineral density. Against this background, the present study aims to analyze the status of bone mineral density in patients with hyperthyroidism along with age and sex matched controls. 70 consecutive patients and controls were analyzed for thyroid function test, BMD parameters and DEXA scan. The values of BMD parameters were analyzed at the baseline in both patients & control group. The baseline values of vitamin D and PTH of both the groups were 19.24±10.15 Vs 28.38±14.56 and 69.81±57.41Vs 58.53±46.49 respectively. BMD at spine and Hip were -1.38±1.31 Vs -0.26±0.80 and -1.02±1.11 Vs -0.22±0.93 respectively. The BMD of total body was 1.044±0.10 Vs 1.160±0.08. Vitamin D deficiency was found to be prevalent in patients with hyperthyroidism along with significantly reduced BMD compared to controls. The occurrence of osteopenia was higher than osteoporosis in the patient group at both lumbar spine and hip region.


Keywords


Hyperthyroidism, thyrotoxicosis, vitamin D, India, bone mineral density, BMD

Full Text:

PDF

References


References

Goswami R, Seth A, Sosnami AK et al., Prevalence of enuresis and other bladder symptoms in patients with active Graves’ disease, “Br J Urol” 1997; 80 (4): 536-46p.

Guleria R, Goswami R, Shah P et al., Dyspnoea, lung function and respiratory muscle presence in patients with Graves’ diseases, “Ind J Med Res” 1996; 104: 299-303p.

Goswami R, Tandon RK, Dudha A et al., Prevalence and significance of steatorrhea in patients with active Graves’ disease, “Am J Gastroenterol” 1998; 93: 1122-25p.

Goswami R, Kochupillai N, Adrenocortical reserve in patients with Graves’ disease, “Eur J Endocrinol” 2001; 144(1): 85p.

Mosekilde L, Christensen MS, “Decreased parathyroid function in hyperthyroidism: inter relationship between serum parathyroid hormone, calcium phosphorus metabolism and thyroid function”, Acta Endocrinol 1977; 84: 566-75p.

Goswami R, Shah P, Ammini AC, Thyrotoxicosis with osteomalacia and proximal myopathy, “J Postgrad Med” 1993; 39(2): 89-90p.

Nagasaka S, Shinobara Y, Kubota K et al., Osteomalacia in a vitamin D deficient woman with Graves’ disease, “Endrocr J” 2001; 48(4): 515-16p.

Goswami R, Gupta N, Goswami G et al., Prevalence and significance of low 25 hydroxy vitamin D concentrations in healthy subjects in Delhi, “Am J Clin Nutr” 2000; 72: 472-75p.

Crooks J, Murray IPC, Wayne EJ, Statistical methods applied to the clinical diagnosis of thyrotoxicosis, “Q J Med.” 1959; 28: 211–34p.

Thorsdottir L. et al., Validity of food frequency questionnaire to assess dietary intake of adults, “Ice Med J” Vol: 90; 37-41p.

Harinarayan CV, Joshi SR, Vitamin D status in India – its implications and remedial measures, “J Assoc Physicians India” 2009; 57: 40-48p.

Arya V, Bhambri R, Godbole MM et al., “Vitamin D status and its relationship with bone mineral density in healthy Asian Indians”, Osteoporos Int 15:56-61p.

Vupputuri MR, Goswami R, Gupta N et al., Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians, “Am J Clin Nutr” 83:1411-19p.

Zargar AH, Ahmad S, Masoodi SR et al., Vitamin D status in apparently healthy adults in Kashmir valley of Indian subcontinent, “Postgrad Med J” 83:713-716p.

Mithal A, Wahl DA, Bonjour JP et al., “Global Global vitamin D status and determinants of hypovitaminosis D Osteoporos”, Int 2009; 11: 1807-20p.

Mosekilde L, Lund B, Sorensen OH et al., “Serum-25-hydroxy cholecalciferol in hyperthyroidism”, Lancet 1977; 1: 806-07p.

Yamashita H, Noguchi S, Takatsu K et al., High prevalence of vitamin D deficiency in Japanese female patients with Graves’ disease, “Endocrine J” 2001; 48 : 63-69p.

Mosekilde L, Lund B, Sorensen OH et al., “Serum 25-hydroxycholecalciferol in hyperthyroidism”, Lancet 1977; 1: 806p.

Velentzas C, Orepoulos DB, From G et al., “Vitamin D levels in thyrotoxcosis”, Lancet 1977; 1: 370-71p.

Fraser A, Anderson J, Smith D et al., “Osteoporosis and fracture risk following thyrotoxicosis”, Lancet 1971 (1): 981-83p.

Tsai KS, Lai SM, Huang KM et al., Decreased bone mineral density in patients with prolonged thyrotoxicosis before and after treatment, “J Formosan Med Arch” 1991; 90: 251-57p.

Udayakumar N, Chandrasekaran M, Rasheed M H et al., Evaluation of bone mineral density in Thyrotoxicosis, “Singapore Med J” 2006; 47(11) : 947p

Dhanwal DK, Kochupillai N, Gupta N et al., Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism, “J Clin Densitom”. 2010 Oct-Dec; 13(4):462-66p.

Viveka P. Jyotsna, Abhay Sahoo, Singh Achouba Ksh et al., Bone mineral density in patients of Graves disease pre- & post treatment in a predominantly vitamin D deficient population, “Indian J Med Res” 135, January 2012, 36-41p.

Dhanwal DK, Gupta N, Bone mineral density trends in Indian patients with hyperthyroidism – Effect of Antithyroid therapy, “JAPI” Sep 2011; 59: 561-67p.


Refbacks

  • There are currently no refbacks.


Copyright (c)